Towa 2B
B2B
Worldwide
We operate worldwide. We are already present in more than 30 countries through our strategic alliances.
We develop and manufacture high-quality generic medicines for pharmaceutical companies and distributors who share our values, our patient-oriented approach and a high level of rigor, quality, safety and efficacy.
We apply two formulas: out-licensing and distribution. Manufacturing and development are mainly carried out in-house.
During 2023 we consolidated our CDMO unit with which we want to be able to offer our partners the possibility to collaborate thanks to our extensive production capacities in Barcelona.
At Towa 2B, we focus on building long-term, value-driven relationships, helping our partners grow while contributing to people’s health.
Our presence
